Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.00029 | 1 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.00022 | 1 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00022 | 1 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |